Skip to main content
Top
Published in: Breast Cancer Research 1/2003

01-02-2003 | Meeting report

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003

Author: Alana L Welm

Published in: Breast Cancer Research | Issue 1/2003

Login to get access

Abstract

The recent meeting 'Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications' was an American Association for Cancer Research (AACR) Special Conference in Cancer Research, for which the underwriting sponsor was the Avon Foundation. Presentations were made from prominent scientists on several relevant basic science and clinic-oriented topics, including mammary stem cells and development, steroid receptors, matrix and stromal–epithelial interactions, oncogene signaling and imaging, genetics and prevention, and molecular therapeutics. A summary of recent findings is presented here, with a particular emphasis on unpublished work.
Metadata
Title
AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003
Author
Alana L Welm
Publication date
01-02-2003
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2003
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr747

Other articles of this Issue 1/2003

Breast Cancer Research 1/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine